PYRAZINAMIDE

PYRAZINAMIDE was reported 9473 times

PYRAZINAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 95 0.5220
1 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 170 0.5075
2 SERPIGINOUS CHOROIDITIS 24 0.5000
3 MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY 5 0.4545
4 TUBERCULOSIS OF EYE 12 0.1714
5 HERBAL TOXICITY 5 0.1667
6 TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM 44 0.1624
7 DIAPHRAGMATIC INJURY 12 0.1622
8 MENINGITIS TUBERCULOUS 90 0.1610
9 PARADOXICAL DRUG REACTION 515 0.1398
10 ENZYME INDUCTION 6 0.1250
11 SIDEROBLASTIC ANAEMIA 16 0.1143
12 TUBERCULOSIS OF GENITOURINARY SYSTEM 10 0.1099
13 MASTITIS BACTERIAL 7 0.1094
14 PULMONARY SEQUESTRATION 6 0.1091
15 TUBERCULOID LEPROSY 7 0.1077
16 SPLENIC EMBOLISM 12 0.1043
17 PERICARDITIS TUBERCULOUS 9 0.0900
18 IMMUNE RECONSTITUTION SYNDROME 110 0.0852
19 TUBERCULOSIS GASTROINTESTINAL 25 0.0784
20 CUTANEOUS TUBERCULOSIS 14 0.0769
21 AIDS RELATED COMPLICATION 5 0.0769
22 ACID FAST BACILLI INFECTION 12 0.0745
23 NICOTINIC ACID DEFICIENCY 8 0.0721
24 HEREDITARY OPTIC ATROPHY 5 0.0714
25 DISSEMINATED TUBERCULOSIS 181 0.0705
26 CHOROIDITIS 25 0.0668
27 LYMPH NODE TUBERCULOSIS 46 0.0618
28 PERITONEAL TUBERCULOSIS 27 0.0615
29 SUBACUTE HEPATIC FAILURE 9 0.0604
30 HEMIANOPIA HETERONYMOUS 5 0.0581
31 CEREBROVASCULAR ARTERIOVENOUS MALFORMATION 5 0.0575
32 BONE TUBERCULOSIS 22 0.0574
33 PULMONARY TUBERCULOSIS 243 0.0568
34 JOINT TUBERCULOSIS 6 0.0536
35 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 265 0.0531
36 PANCREATITIS HAEMORRHAGIC 24 0.0515
37 EXTRAPULMONARY TUBERCULOSIS 15 0.0508
38 LYMPH NODE ABSCESS 5 0.0490
39 VITAMIN B1 DECREASED 12 0.0478
40 TUBERCULOUS PLEURISY 22 0.0465
41 OEDEMATOUS KIDNEY 12 0.0453
42 TOXIC OPTIC NEUROPATHY 19 0.0438
43 GRANULOMATOUS LYMPHADENITIS 8 0.0428
44 INTESTINAL TUBERCULOSIS 7 0.0402
45 URINARY TRACT INFLAMMATION 14 0.0389
46 DANDY-WALKER SYNDROME 10 0.0386
47 DELUSION OF REFERENCE 5 0.0360
48 MYCOBACTERIUM TEST POSITIVE 7 0.0340
49 TESTICULAR MASS 7 0.0320
50 CONDUCTIVE DEAFNESS 10 0.0312
51 VISUAL PATHWAY DISORDER 5 0.0311
52 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 36 0.0300
53 GRANULOMATOUS LIVER DISEASE 21 0.0298
54 HEPATITIS TOXIC 77 0.0295
55 JARISCH-HERXHEIMER REACTION 21 0.0295
56 SEVERE CUTANEOUS ADVERSE REACTION 7 0.0293
57 OEDEMATOUS PANCREATITIS 15 0.0267
58 PYELONEPHRITIS CHRONIC 5 0.0266
59 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 685 0.0266
60 ANTIPSYCHOTIC DRUG LEVEL DECREASED 14 0.0264
61 OPTIC NEUROPATHY 55 0.0260
62 CENTRAL NERVOUS SYSTEM VASCULITIS 13 0.0255
63 SPLENIC ABSCESS 10 0.0246
64 MYCOBACTERIUM ABSCESSUS INFECTION 17 0.0238
65 ACCELERATED HYPERTENSION 9 0.0237
66 THALAMIC INFARCTION 14 0.0236
67 DISSEMINATED CYTOMEGALOVIRAL INFECTION 5 0.0231
68 MULTIPLE-DRUG RESISTANCE 70 0.0226
69 DRUG-INDUCED LIVER INJURY 662 0.0211
70 PSOAS ABSCESS 13 0.0209
71 MARROW HYPERPLASIA 14 0.0205
72 BIOPSY LIVER ABNORMAL 6 0.0199
73 KAPOSI'S SARCOMA 10 0.0199
74 MYCOBACTERIAL INFECTION 34 0.0197
75 TRICHOGLOSSIA 8 0.0195
76 OTOTOXICITY 35 0.0189
77 ARACHNOIDITIS 12 0.0173
78 ACUTE HEPATIC FAILURE 236 0.0173
79 ANGINA BULLOSA HAEMORRHAGICA 4 0.0172
80 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 8 0.0171
81 DILATATION INTRAHEPATIC DUCT ACQUIRED 5 0.0171
82 LOW SET EARS 7 0.0170
83 HEPATOTOXICITY 376 0.0169
84 HEPATITIS FULMINANT 50 0.0168
85 NEUROPSYCHOLOGICAL SYMPTOMS 10 0.0166
86 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 18 0.0164
87 HYPERURICAEMIA 66 0.0160
88 SPUTUM CULTURE POSITIVE 13 0.0160
89 EXTRAOCULAR MUSCLE DISORDER 5 0.0154
90 CNS VENTRICULITIS 5 0.0153
91 CENTRAL NERVOUS SYSTEM INFLAMMATION 5 0.0151
92 GRANULOMA 49 0.0141
93 PULMONARY GRANULOMA 16 0.0140
94 INSULIN AUTOIMMUNE SYNDROME 5 0.0140
95 DRUG RESISTANCE 360 0.0140
96 HYDROCEPHALUS 74 0.0136
97 HEPATIC ATROPHY 6 0.0134
98 VASCULITIS CEREBRAL 6 0.0133
99 RENAL TRANSPLANT FAILURE 13 0.0132
100 CEREBRAL TOXOPLASMOSIS 12 0.0128
101 ADRENOCORTICAL INSUFFICIENCY ACUTE 25 0.0128
102 LIVER TRANSPLANT REJECTION 23 0.0128
103 CHRONIC ALLOGRAFT NEPHROPATHY 10 0.0128
104 TYPE III IMMUNE COMPLEX MEDIATED REACTION 7 0.0125
105 HILAR LYMPHADENOPATHY 11 0.0125
106 CAT SCRATCH DISEASE 5 0.0124
107 ACANTHOSIS 4 0.0122
108 COMA HEPATIC 9 0.0121
109 CHOLESTATIC LIVER INJURY 27 0.0121
110 PROTRUSION TONGUE 7 0.0120
111 LICHENOID KERATOSIS 26 0.0114
112 HYPERMETABOLISM 6 0.0113
113 VESTIBULAR NEURONITIS 6 0.0112
114 LYMPHOCYTE STIMULATION TEST POSITIVE 9 0.0112
115 TRISOMY 21 14 0.0111
116 CHYLOTHORAX 8 0.0111
117 GLOMERULONEPHRITIS MINIMAL LESION 8 0.0110
118 DISTRIBUTIVE SHOCK 24 0.0106
119 HEPATIC ENCEPHALOPATHY 98 0.0105
120 RENAL ATROPHY 13 0.0104
121 ABDOMINAL LYMPHADENOPATHY 9 0.0104
122 HYPERTRANSAMINASAEMIA 72 0.0103
123 HEPATITIS 260 0.0102
124 NEUROPSYCHIATRIC SYMPTOMS 9 0.0100
125 DRUG LEVEL DECREASED 98 0.0096
126 JAUNDICE 256 0.0095
127 DRUG LEVEL ABNORMAL 5 0.0094
128 BILIRUBIN CONJUGATED INCREASED 22 0.0094
129 CEREBELLAR ATAXIA 9 0.0094
130 CHORIORETINITIS 6 0.0093
131 BLOOD IMMUNOGLOBULIN A INCREASED 5 0.0093
132 LYMPHADENITIS 22 0.0091
133 HYPERTENSIVE URGENCY 5 0.0090
134 ACUTE LEFT VENTRICULAR FAILURE 6 0.0089
135 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 29 0.0089
136 LYMPHADENOPATHY MEDIASTINAL 17 0.0089
137 INTENTION TREMOR 5 0.0088
138 COLOUR BLINDNESS 8 0.0087
139 RESPIRATORY ALKALOSIS 14 0.0086
140 SJS-TEN OVERLAP 6 0.0085
141 MALARIA 6 0.0085
142 HEPATIC NECROSIS 32 0.0085
143 CSF PROTEIN INCREASED 7 0.0084
144 TRANSPLANT DYSFUNCTION 15 0.0084
145 RASH MORBILLIFORM 23 0.0083
146 HEPATOSPLENOMEGALY 21 0.0082
147 OCULAR TOXICITY 9 0.0082
148 INFECTIOUS PLEURAL EFFUSION 12 0.0079
149 DIAPHRAGMATIC DISORDER 6 0.0078
150 OSTEOLYSIS 16 0.0078
151 CEREBRAL VENTRICLE DILATATION 9 0.0078
152 SKULL MALFORMATION 5 0.0078
153 BLOOD MAGNESIUM INCREASED 7 0.0078
154 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 6 0.0077
155 URETERIC STENOSIS 6 0.0075
156 PLACENTAL INSUFFICIENCY 6 0.0075
157 PATHOGEN RESISTANCE 68 0.0075
158 SPLENIC INFARCTION 13 0.0074
159 MENINGITIS CRYPTOCOCCAL 13 0.0074
160 LIVER TRANSPLANT 27 0.0074
161 CACHEXIA 38 0.0074
162 PLEURAL THICKENING 5 0.0073
163 ACINETOBACTER INFECTION 8 0.0073
164 LEUKOCYTURIA 6 0.0073
165 EPIDERMAL NECROSIS 7 0.0072
166 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 11 0.0072
167 PSEUDOMEMBRANOUS COLITIS 16 0.0072
168 OPTIC NEURITIS 65 0.0071
169 DUODENAL PERFORATION 7 0.0071
170 GRAFT LOSS 5 0.0069
171 EOSINOPHILIC MYOCARDITIS 5 0.0068
172 RED MAN SYNDROME 6 0.0068
173 ENCEPHALITIS 47 0.0068
174 OPTIC ATROPHY 11 0.0067
175 MYCOBACTERIUM AVIUM COMPLEX INFECTION 18 0.0067
176 EOSINOPHILIA 117 0.0067
177 HYPERBILIRUBINAEMIA 69 0.0067
178 BLOOD HIV RNA INCREASED 12 0.0066
179 CD4 LYMPHOCYTES DECREASED 14 0.0065
180 KIDNEY ENLARGEMENT 7 0.0064
181 CARDIOPULMONARY FAILURE 25 0.0064
182 ARTERITIS 4 0.0063
183 HIV INFECTION 19 0.0063
184 COR PULMONALE 6 0.0063
185 CRYPTOCOCCOSIS 10 0.0061
186 MITOCHONDRIAL TOXICITY 5 0.0061
187 DYSBIOSIS 5 0.0061
188 ELECTROCARDIOGRAM QT PROLONGED 219 0.0061
189 VACCINATION FAILURE 10 0.0060
190 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 45 0.0060
191 TRANSAMINASES INCREASED 132 0.0059
192 BRAIN ABSCESS 15 0.0059
193 GRANULOMATOSIS WITH POLYANGIITIS 7 0.0058
194 BILE DUCT OBSTRUCTION 11 0.0058
195 ANGULAR CHEILITIS 4 0.0058
196 OESOPHAGEAL CANDIDIASIS 23 0.0058
197 HEPATOCELLULAR DAMAGE 13 0.0058
198 AXONAL NEUROPATHY 5 0.0057
199 VESTIBULAR DISORDER 7 0.0057
200 THERAPEUTIC PRODUCT CROSS-REACTIVITY 5 0.0056
201 HENOCH-SCHONLEIN PURPURA 12 0.0055
202 LYMPH NODE PAIN 10 0.0054
203 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 12 0.0054
204 MIXED LIVER INJURY 16 0.0053
205 HEPATITIS CHOLESTATIC 32 0.0053
206 ACTINOMYCOSIS 5 0.0052
207 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 4 0.0052
208 GLYCOSURIA 7 0.0052
209 ASPERGILLUS INFECTION 34 0.0052
210 IMPLANT SITE INFECTION 12 0.0052
211 CYTOMEGALOVIRUS CHORIORETINITIS 10 0.0051
212 LYMPHADENECTOMY 5 0.0051
213 BICYTOPENIA 10 0.0051
214 FUNGAEMIA 8 0.0051
215 PNEUMOCYSTIS JIROVECII INFECTION 6 0.0050
216 INTRACRANIAL PRESSURE INCREASED 28 0.0050
217 AUTOIMMUNE HAEMOLYTIC ANAEMIA 17 0.0050
218 FALSE POSITIVE INVESTIGATION RESULT 5 0.0050
219 ATYPICAL MYCOBACTERIAL INFECTION 7 0.0049
220 BUTTERFLY RASH 5 0.0049
221 MENINGITIS BACTERIAL 7 0.0049
222 HEPATOMEGALY 48 0.0049
223 IMMUNE SYSTEM DISORDER 64 0.0049
224 HELICOBACTER GASTRITIS 6 0.0048
225 RASH MACULO-PAPULAR 106 0.0048
226 BLOOD BICARBONATE DECREASED 9 0.0047
227 NEPHRITIS INTERSTITIAL 6 0.0047
228 TYPE IV HYPERSENSITIVITY REACTION 13 0.0047
229 NECROSIS 26 0.0047
230 TOXOPLASMOSIS 5 0.0046
231 COMA SCALE ABNORMAL 13 0.0045
232 HYPERLACTACIDAEMIA 12 0.0045
233 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 5 0.0045
234 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 11 0.0044
235 STENOTROPHOMONAS INFECTION 6 0.0044
236 COMPUTERISED TOMOGRAM ABNORMAL 10 0.0044
237 DERMATITIS EXFOLIATIVE 22 0.0044
238 OCULAR ICTERUS 19 0.0044
239 LYMPHADENOPATHY 155 0.0044
240 CENTRAL NERVOUS SYSTEM INFECTION 5 0.0044
241 POLYNEUROPATHY 52 0.0043
242 DEATH NEONATAL 6 0.0043
243 LUNG CONSOLIDATION 12 0.0043
244 SPLENIC RUPTURE 7 0.0043
245 DEAFNESS NEUROSENSORY 14 0.0043
246 HEPATIC FAILURE 128 0.0042
247 TRANSPLANT REJECTION 34 0.0042
248 BONE MARROW TOXICITY 5 0.0042
249 OLIGOHYDRAMNIOS 14 0.0042
250 HYPERSENSITIVITY VASCULITIS 11 0.0042
251 LYMPHOCYTOSIS 9 0.0042
252 ORAL CANDIDIASIS 55 0.0042
253 LABELLED DRUG-DRUG INTERACTION ISSUE 6 0.0041
254 CHRONIC RESPIRATORY FAILURE 5 0.0041
255 BLOOD IMMUNOGLOBULIN G INCREASED 5 0.0041
256 GAZE PALSY 7 0.0041
257 CLOSTRIDIUM DIFFICILE COLITIS 43 0.0041
258 MYASTHENIA GRAVIS CRISIS 6 0.0040
259 MENINGITIS 27 0.0040
260 DERMATITIS EXFOLIATIVE GENERALISED 14 0.0040
261 SPLENOMEGALY 47 0.0040
262 PERSECUTORY DELUSION 10 0.0040
263 BLOOD URIC ACID INCREASED 23 0.0040
264 DRUG INTERACTION 628 0.0040
265 MYOGLOBIN BLOOD INCREASED 6 0.0039
266 MICROCYTIC ANAEMIA 8 0.0038
267 PROTHROMBIN TIME PROLONGED 23 0.0038
268 ASPERGILLOSIS 5 0.0038
269 PNEUMONIA KLEBSIELLA 7 0.0038
270 DRUG LEVEL BELOW THERAPEUTIC 21 0.0038
271 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 9 0.0038
272 DISSEMINATED INTRAVASCULAR COAGULATION 53 0.0038
273 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6 0.0037
274 ALANINE AMINOTRANSFERASE INCREASED 230 0.0037
275 TUBULOINTERSTITIAL NEPHRITIS 70 0.0037
276 HYPERREFLEXIA 13 0.0037
277 OCULOGYRIC CRISIS 8 0.0037
278 STILLBIRTH 18 0.0037
279 BRAIN OEDEMA 47 0.0037
280 VULVOVAGINAL CANDIDIASIS 5 0.0037
281 ASPARTATE AMINOTRANSFERASE INCREASED 196 0.0037
282 TOXIC EPIDERMAL NECROLYSIS 56 0.0037
283 LYMPHOPENIA 52 0.0037
284 DRUG ERUPTION 65 0.0037
285 ACUTE PSYCHOSIS 9 0.0036
286 MACULE 10 0.0036
287 PNEUMOCYSTIS JIROVECI PNEUMONIA 8 0.0036
288 NYSTAGMUS 19 0.0036
289 HALLUCINATIONS, MIXED 15 0.0036
290 CEREBELLAR INFARCTION 6 0.0035
291 ANTICONVULSANT DRUG LEVEL DECREASED 5 0.0035
292 LIVER INJURY 86 0.0035
293 IMMUNE THROMBOCYTOPENIA 16 0.0035
294 PANCREATIC ENZYMES INCREASED 5 0.0034
295 BLOOD BILIRUBIN INCREASED 92 0.0034
296 LIVER ABSCESS 11 0.0034
297 PSYCHIATRIC SYMPTOM 25 0.0034
298 HEPATITIS ACUTE 22 0.0034
299 PARAPARESIS 6 0.0034
300 HAEMOLYTIC ANAEMIA 30 0.0033
301 BRAIN HERNIATION 10 0.0033
302 PAPILLOEDEMA 15 0.0033
303 WOUND DEHISCENCE 11 0.0033
304 PULMONARY TOXICITY 23 0.0032
305 OPPORTUNISTIC INFECTION 6 0.0032
306 LIVER FUNCTION TEST ABNORMAL 94 0.0032
307 ELECTROCARDIOGRAM T WAVE ABNORMAL 5 0.0032
308 BLOOD CREATININE DECREASED 10 0.0032
309 LUNG INFILTRATION 28 0.0032
310 LOW BIRTH WEIGHT BABY 25 0.0031
311 TYPE I HYPERSENSITIVITY 11 0.0031
312 PULSELESS ELECTRICAL ACTIVITY 13 0.0031
313 APGAR SCORE LOW 4 0.0031
314 ANTINUCLEAR ANTIBODY POSITIVE 10 0.0031
315 NEUROPATHY PERIPHERAL 292 0.0031
316 HEPATIC FUNCTION ABNORMAL 114 0.0031
317 PURPURA 27 0.0030
318 BLOOD ALBUMIN DECREASED 24 0.0030
319 CYTOLYTIC HEPATITIS 10 0.0030
320 COAGULOPATHY 50 0.0030
321 AREFLEXIA 8 0.0030
322 NORMOCHROMIC NORMOCYTIC ANAEMIA 9 0.0030
323 ALCOHOL ABUSE 8 0.0030
324 ENTEROBACTER INFECTION 5 0.0030
325 HEPATOCELLULAR INJURY 42 0.0030
326 HYPOVOLAEMIC SHOCK 14 0.0029
327 HEPATIC CYTOLYSIS 37 0.0029
328 IRIDOCYCLITIS 9 0.0028
329 ALANINE AMINOTRANSFERASE ABNORMAL 6 0.0028
330 RETROPERITONEAL HAEMORRHAGE 7 0.0028
331 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 22 0.0028
332 JAUNDICE CHOLESTATIC 10 0.0028
333 HYPOALBUMINAEMIA 22 0.0028
334 ABDOMINAL TENDERNESS 14 0.0028
335 CHOLESTASIS 54 0.0028
336 ASCITES 82 0.0028
337 GENERALISED TONIC-CLONIC SEIZURE 46 0.0028
338 ACUTE RESPIRATORY DISTRESS SYNDROME 49 0.0028
339 CUTANEOUS VASCULITIS 10 0.0027
340 ELECTROCARDIOGRAM T WAVE INVERSION 6 0.0027
341 APRAXIA 4 0.0027
342 NEUROTOXICITY 47 0.0027
343 PSEUDOMONAS INFECTION 23 0.0027
344 PREMATURE LABOUR 15 0.0027
345 COMPLICATIONS OF TRANSPLANTED KIDNEY 6 0.0026
346 PANCREATITIS ACUTE 59 0.0026
347 GAMMA-GLUTAMYLTRANSFERASE INCREASED 58 0.0026
348 CHEST X-RAY ABNORMAL 8 0.0026
349 HYPOREFLEXIA 5 0.0026
350 VIROLOGIC FAILURE 14 0.0026
351 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 23 0.0026
352 PANCYTOPENIA 145 0.0026
353 PSYCHOTIC DISORDER 75 0.0025
354 GASTROENTERITIS 37 0.0025
355 PLEURISY 15 0.0025
356 CELL DEATH 5 0.0025
357 LONG QT SYNDROME 6 0.0025
358 HYPOKALAEMIA 115 0.0025
359 STUPOR 8 0.0025
360 PARTIAL SEIZURES 13 0.0025
361 POLYURIA 20 0.0024
362 AMYLASE INCREASED 9 0.0024
363 OLIGURIA 15 0.0024
364 LIVEDO RETICULARIS 5 0.0024
365 KLEBSIELLA INFECTION 12 0.0024
366 MULTIPLE ORGAN DYSFUNCTION SYNDROME 67 0.0024
367 TORTICOLLIS 5 0.0024
368 HISTIOCYTOSIS HAEMATOPHAGIC 7 0.0024
369 PURULENT DISCHARGE 10 0.0023
370 ENCEPHALOPATHY 57 0.0023
371 VASCULITIS 27 0.0023
372 NEPHROPATHY TOXIC 26 0.0023
373 DYSAESTHESIA 7 0.0023
374 CEREBELLAR SYNDROME 5 0.0023
375 EOSINOPHIL COUNT INCREASED 19 0.0023
376 INTERNATIONAL NORMALISED RATIO INCREASED 65 0.0023
377 LUNG OPACITY 6 0.0023
378 PAPULE 16 0.0023
379 ALTERED STATE OF CONSCIOUSNESS 49 0.0023
380 BACTERIAL TEST POSITIVE 5 0.0022
381 ABDOMINAL MASS 6 0.0022
382 SKIN HYPERPIGMENTATION 19 0.0022
383 TACHYPNOEA 30 0.0022
384 PREMATURE DELIVERY 35 0.0022
385 SEROTONIN SYNDROME 42 0.0022
386 GENERALISED OEDEMA 27 0.0022
387 BLOOD ALKALINE PHOSPHATASE INCREASED 54 0.0022
388 PLEURITIC PAIN 6 0.0022
389 VIRAL MUTATION IDENTIFIED 8 0.0022
390 PERICARDIAL EFFUSION 50 0.0022
391 NEUROLOGICAL DECOMPENSATION 5 0.0022
392 PNEUMOTHORAX 34 0.0021
393 HEPATIC ENZYME INCREASED 146 0.0021
394 DYSMORPHISM 5 0.0021
395 LEUKOPENIA 106 0.0021
396 PUSTULE 5 0.0021
397 PIGMENTATION DISORDER 13 0.0021
398 HAEMODYNAMIC INSTABILITY 16 0.0021
399 URINARY HESITATION 5 0.0021
400 ACIDOSIS 16 0.0021
401 POTENTIATING DRUG INTERACTION 7 0.0021
402 TOXIC SKIN ERUPTION 21 0.0021
403 GASTROINTESTINAL OBSTRUCTION 5 0.0021
404 DIABETES INSIPIDUS 5 0.0021
405 FACE OEDEMA 35 0.0021
406 RESPIRATORY FAILURE 151 0.0021
407 BRONCHOPULMONARY ASPERGILLOSIS 16 0.0021
408 PERIPHERAL SENSORY NEUROPATHY 12 0.0021
409 HEMIPLEGIA 17 0.0020
410 ANAEMIA 389 0.0020
411 HAEMODIALYSIS 17 0.0020
412 STEVENS-JOHNSON SYNDROME 45 0.0020
413 POLYDIPSIA 8 0.0020
414 ATAXIA 24 0.0020
415 INFLAMMATORY MARKER INCREASED 10 0.0020
416 CREPITATIONS 6 0.0020
417 CEREBRAL ATROPHY 8 0.0020
418 SHOCK 46 0.0020
419 HEPATITIS B 12 0.0020
420 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 10 0.0020
421 TOXIC ENCEPHALOPATHY 10 0.0020
422 FOETAL GROWTH RESTRICTION 12 0.0020
423 MYOPATHY 17 0.0020
424 RESPIRATORY DISTRESS 54 0.0020
425 BLOOD CHLORIDE DECREASED 5 0.0019
426 LEUKOCYTOSIS 35 0.0019
427 SKIN NECROSIS 10 0.0019
428 IMMUNOSUPPRESSION 17 0.0019
429 MUCORMYCOSIS 5 0.0019
430 PREGNANCY WITH IMPLANT CONTRACEPTIVE 9 0.0019
431 KIDNEY TRANSPLANT REJECTION 9 0.0019
432 LUNG NEOPLASM 8 0.0019
433 SKIN EROSION 6 0.0019
434 ANURIA 16 0.0019
435 PLEURAL EFFUSION 113 0.0019
436 PEMPHIGOID 14 0.0019
437 BLOOD SODIUM INCREASED 5 0.0019
438 THROMBOCYTOPENIA 206 0.0018
439 SEPTIC SHOCK 79 0.0018
440 TENOSYNOVITIS 5 0.0018
441 SKIN DISORDER 60 0.0018
442 HYPOMAGNESAEMIA 25 0.0018
443 MALNUTRITION 20 0.0018
444 SKIN LESION 49 0.0018
445 ACUTE PULMONARY OEDEMA 10 0.0018
446 BLOOD CALCIUM DECREASED 20 0.0018
447 ACUTE RESPIRATORY FAILURE 34 0.0018
448 DEAFNESS 46 0.0018
449 HAEMOPTYSIS 49 0.0018
450 NEPHROTIC SYNDROME 12 0.0017
451 DERMATITIS ALLERGIC 22 0.0017
452 HEPATIC FIBROSIS 6 0.0017
453 PYREXIA 603 0.0017
454 TREATMENT FAILURE 144 0.0017
455 MULTI-ORGAN FAILURE 30 0.0017
456 TREATMENT NONCOMPLIANCE 94 0.0017
457 PNEUMOCYSTIS JIROVECII PNEUMONIA 17 0.0017
458 HAEMOLYSIS 13 0.0017
459 CARDIAC TAMPONADE 8 0.0017
460 CONJUNCTIVAL HYPERAEMIA 6 0.0017
461 LIVER FUNCTION TEST INCREASED 36 0.0017
462 BLOOD UREA INCREASED 28 0.0017
463 BLOOD PHOSPHORUS DECREASED 6 0.0016
464 THROMBOCYTOSIS 6 0.0016
465 ELECTROLYTE IMBALANCE 19 0.0016
466 BLOOD THYROID STIMULATING HORMONE INCREASED 15 0.0016
467 HYPOTHYROIDISM 52 0.0016
468 SMALL FOR DATES BABY 8 0.0016
469 ERYTHEMA MULTIFORME 15 0.0016
470 HEMIPARESIS 27 0.0016
471 BLOOD SODIUM DECREASED 30 0.0016
472 EXPOSURE DURING PREGNANCY 98 0.0016
473 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 6 0.0016
474 ORTHOPNOEA 5 0.0016
475 AMMONIA INCREASED 8 0.0016
476 LIPASE INCREASED 12 0.0016
477 RENAL FAILURE ACUTE 66 0.0016
478 SINUS TACHYCARDIA 22 0.0015
479 FAILURE TO THRIVE 8 0.0015
480 PETECHIAE 16 0.0015
481 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 9 0.0015
482 INTESTINAL PERFORATION 17 0.0015
483 OTITIS MEDIA 5 0.0015
484 FISTULA 17 0.0015
485 REBOUND EFFECT 17 0.0015
486 EMPHYSEMA 15 0.0015
487 HYPOCALCAEMIA 28 0.0015
488 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 14 0.0015
489 APLASIA PURE RED CELL 5 0.0015
490 RED BLOOD CELL SEDIMENTATION RATE INCREASED 16 0.0014
491 GASTRITIS 38 0.0014
492 LIVER DISORDER 64 0.0014
493 METABOLIC ACIDOSIS 46 0.0014
494 HYPERTENSIVE CRISIS 16 0.0014
495 PREMATURE BABY 43 0.0014
496 MUSCLE CONTRACTIONS INVOLUNTARY 5 0.0014
497 BREATH SOUNDS ABNORMAL 7 0.0014
498 THROMBOTIC THROMBOCYTOPENIC PURPURA 5 0.0014
499 PNEUMONIA BACTERIAL 13 0.0014
500 DELIRIUM 49 0.0014
501 LEFT VENTRICULAR HYPERTROPHY 6 0.0014
502 ANOREXIA 18 0.0014
503 LACTIC ACIDOSIS 45 0.0014
504 HERPES VIRUS INFECTION 8 0.0014
505 VISUAL FIELD DEFECT 10 0.0014
506 REFUSAL OF TREATMENT BY PATIENT 9 0.0014
507 ABORTION 4 0.0014
508 PROTEINURIA 26 0.0014
509 UPPER GASTROINTESTINAL HAEMORRHAGE 23 0.0014
510 BLOOD CREATINE INCREASED 6 0.0014
511 C-REACTIVE PROTEIN INCREASED 49 0.0013
512 ATELECTASIS 13 0.0013
513 UVEITIS 18 0.0013
514 GRAND MAL CONVULSION 12 0.0013
515 HYPERCALCAEMIA 16 0.0013
516 ANKYLOSING SPONDYLITIS 17 0.0013
517 BONE MARROW FAILURE 26 0.0013
518 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 13 0.0013
519 VISUAL ACUITY REDUCED 42 0.0013
520 BACTERAEMIA 15 0.0013
521 RENAL IMPAIRMENT 106 0.0013
522 SUBCUTANEOUS ABSCESS 6 0.0013
523 CANDIDIASIS 5 0.0012
524 BLOOD CREATININE INCREASED 81 0.0012
525 PRODUCT PRESCRIBING ISSUE 27 0.0012
526 CENTRAL NERVOUS SYSTEM LESION 17 0.0012
527 CEREBRAL INFARCTION 30 0.0012
528 PLATELET COUNT INCREASED 16 0.0012
529 CARDIOMYOPATHY 18 0.0012
530 SELF-MEDICATION 5 0.0012
531 RASH ERYTHEMATOUS 58 0.0012
532 ORGANISING PNEUMONIA 6 0.0012
533 PERITONITIS 25 0.0012
534 RALES 7 0.0012
535 GASTROINTESTINAL PERFORATION 5 0.0012
536 HYPONATRAEMIA 67 0.0012
537 BRONCHIECTASIS 8 0.0012
538 SKIN PLAQUE 10 0.0012
539 DYSLIPIDAEMIA 6 0.0012
540 LIP OEDEMA 5 0.0012
541 ACUTE KIDNEY INJURY 177 0.0012
542 SEPSIS 129 0.0012
543 ADRENAL INSUFFICIENCY 14 0.0012
544 STATUS EPILEPTICUS 13 0.0011
545 MYELOSUPPRESSION 41 0.0011
546 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
547 IRON DEFICIENCY 5 0.0011
548 CONDITION AGGRAVATED 337 0.0011
549 INCORRECT PRODUCT ADMINISTRATION DURATION 24 0.0011
550 THERAPY NON-RESPONDER 49 0.0011
551 PULMONARY MASS 16 0.0011
552 VENTRICULAR EXTRASYSTOLES 11 0.0011
553 NEUTROPHILIA 6 0.0011
554 VOMITING 492 0.0010
555 BLOOD MAGNESIUM DECREASED 9 0.0010
556 PULMONARY FIBROSIS 20 0.0010
557 PANCREATITIS 55 0.0010
558 HAEMOGLOBIN DECREASED 105 0.0010
559 RENAL TUBULAR NECROSIS 10 0.0010
560 GASTROINTESTINAL DISORDER 91 0.0010
561 BLOOD LACTATE DEHYDROGENASE INCREASED 16 0.0010
562 CANDIDA INFECTION 17 0.0010
563 ODYNOPHAGIA 6 0.0010
564 PROTEIN URINE PRESENT 5 0.0010
565 LUPUS-LIKE SYNDROME 9 0.0010
566 HAEMATEMESIS 25 0.0010
567 DEPRESSED LEVEL OF CONSCIOUSNESS 39 0.0010
568 SHOCK HAEMORRHAGIC 8 0.0010
569 NEUTROPENIC SEPSIS 7 0.0010
570 CARDIOGENIC SHOCK 14 0.0010
571 LARYNGEAL OEDEMA 6 0.0010
572 ANAPHYLACTOID REACTION 4 0.0010
573 AGRANULOCYTOSIS 18 0.0010
574 EMBOLISM 8 0.0010
575 BLEPHAROSPASM 6 0.0010
576 CATATONIA 5 0.0010
577 SERUM FERRITIN INCREASED 5 0.0009
578 GOUT 17 0.0009
579 HALLUCINATION, VISUAL 20 0.0009
580 SUDDEN DEATH 10 0.0009
581 STAPHYLOCOCCAL INFECTION 31 0.0009
582 FACIAL PARALYSIS 8 0.0009
583 HYPERTHERMIA 7 0.0009
584 FOETAL EXPOSURE DURING PREGNANCY 74 0.0009
585 DRUG LEVEL INCREASED 15 0.0009
586 ABDOMINAL ABSCESS 4 0.0009
587 HEPATIC CIRRHOSIS 17 0.0009
588 DYSARTHRIA 34 0.0009
589 RESPIRATORY RATE INCREASED 8 0.0009
590 CARDIAC FAILURE ACUTE 6 0.0009
591 MENTAL STATUS CHANGES 25 0.0009
592 SKIN MASS 6 0.0009
593 RESPIRATORY DEPRESSION 11 0.0009
594 CHOLECYSTITIS CHRONIC 6 0.0009
595 PERICARDITIS 15 0.0009
596 DIPLOPIA 23 0.0009
597 HYPERKALAEMIA 31 0.0009
598 DRUG TOXICITY 12 0.0009
599 GENERALISED ERYTHEMA 5 0.0009
600 INTENTIONAL PRODUCT USE ISSUE 77 0.0009
601 GRANULOCYTOPENIA 5 0.0009
602 BLOOD DISORDER 7 0.0009
603 TINNITUS 40 0.0009
604 BLOOD POTASSIUM DECREASED 26 0.0009
605 HYPERVENTILATION 5 0.0009
606 METABOLIC DISORDER 5 0.0009
607 HICCUPS 7 0.0009
608 MENTAL DISORDER 37 0.0008
609 PULMONARY OEDEMA 38 0.0008
610 SEIZURE 98 0.0008
611 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
612 CYTOMEGALOVIRUS INFECTION 14 0.0008
613 HAEMATOTOXICITY 8 0.0008
614 DISEASE RECURRENCE 40 0.0008
615 TENDONITIS 13 0.0008
616 NEUTROPENIA 114 0.0008
617 NIGHT SWEATS 27 0.0008
618 LIVE BIRTH 7 0.0008
619 RASH PUSTULAR 6 0.0008
620 ARRHYTHMIA 39 0.0008
621 AUTOIMMUNE DISORDER 8 0.0008
622 HALLUCINATION, AUDITORY 13 0.0008
623 CYTOPENIA 10 0.0008
624 VENTRICULAR FIBRILLATION 9 0.0008
625 BLINDNESS 33 0.0008
626 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 44 0.0008
627 URINE OUTPUT DECREASED 7 0.0008
628 BLOOD POTASSIUM INCREASED 13 0.0008
629 NAIL DISORDER 7 0.0008
630 CHROMATURIA 18 0.0008
631 HYPOXIA 28 0.0008
632 EYELID PTOSIS 8 0.0008
633 MATERNAL DRUGS AFFECTING FOETUS 6 0.0008
634 ENTERITIS 5 0.0008
635 SKIN REACTION 11 0.0008
636 HERPES SIMPLEX 5 0.0008
637 THERAPY PARTIAL RESPONDER 12 0.0008
638 DRUG SPECIFIC ANTIBODY PRESENT 5 0.0008
639 RHABDOMYOLYSIS 32 0.0008
640 TENDON DISORDER 5 0.0008
641 BRADYPHRENIA 5 0.0008
642 HAEMATOCRIT DECREASED 15 0.0008
643 OEDEMA 41 0.0008
644 CHOLECYSTITIS 9 0.0008
645 CONFUSIONAL STATE 120 0.0007
646 GENERAL PHYSICAL HEALTH DETERIORATION 85 0.0007
647 PNEUMONITIS 20 0.0007
648 SMALL INTESTINAL OBSTRUCTION 9 0.0007
649 ESCHERICHIA INFECTION 6 0.0007
650 TOXICITY TO VARIOUS AGENTS 123 0.0007
651 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 6 0.0007
652 HYPOGLYCAEMIA 35 0.0007
653 PNEUMONIA ASPIRATION 18 0.0007
654 EPILEPSY 22 0.0007
655 PRODUCT USE IN UNAPPROVED INDICATION 176 0.0007
656 MYOCARDIAL ISCHAEMIA 8 0.0007
657 OSTEONECROSIS 23 0.0007
658 ANAPHYLACTIC SHOCK 18 0.0007
659 TACHYCARDIA 62 0.0007
660 DECREASED APPETITE 162 0.0007
661 PRURITUS GENERALISED 15 0.0007
662 HYPOTHERMIA 7 0.0007
663 CARDIAC ARREST 57 0.0007
664 INTESTINAL OBSTRUCTION 26 0.0007
665 RASH PRURITIC 37 0.0007
666 WHITE BLOOD CELL COUNT INCREASED 26 0.0007
667 MATERNAL EXPOSURE DURING PREGNANCY 60 0.0007
668 FEELING DRUNK 5 0.0007
669 MANIA 11 0.0007
670 RENAL FAILURE 88 0.0007
671 JOINT DISLOCATION 7 0.0007
672 PALLOR 18 0.0007
673 TENDON PAIN 5 0.0007
674 INFLAMMATION 34 0.0007
675 PRODUCTIVE COUGH 31 0.0006
676 ATRIOVENTRICULAR BLOCK 5 0.0006
677 DEEP VEIN THROMBOSIS 42 0.0006
678 ILEUS 8 0.0006
679 NEPHROPATHY 6 0.0006
680 HAEMATURIA 22 0.0006
681 DISEASE PROGRESSION 76 0.0006
682 PULMONARY HAEMORRHAGE 5 0.0006
683 WOUND INFECTION 7 0.0006
684 HYPOTENSION 128 0.0006
685 ABORTION INDUCED 6 0.0006
686 ANGIOEDEMA 28 0.0006
687 FOOT DEFORMITY 7 0.0006
688 RENAL CYST 5 0.0006
689 ULCER 10 0.0006
690 ABDOMINAL PAIN 146 0.0006
691 RASH PAPULAR 14 0.0006
692 MYDRIASIS 8 0.0006
693 MIOSIS 5 0.0006
694 RHINITIS 5 0.0006
695 RASH GENERALISED 16 0.0006
696 ANAPHYLACTIC REACTION 34 0.0006
697 NODULE 8 0.0006
698 ASPHYXIA 5 0.0006
699 COMA 29 0.0006
700 OFF LABEL USE 532 0.0006
701 HYPOACUSIS 26 0.0006
702 ACUTE CORONARY SYNDROME 5 0.0006
703 ATRIOVENTRICULAR BLOCK COMPLETE 4 0.0006
704 VAGINAL DISCHARGE 6 0.0006
705 CONJUNCTIVITIS 11 0.0006
706 HEPATIC STEATOSIS 11 0.0006
707 BACTERIAL INFECTION 11 0.0006
708 DISORIENTATION 23 0.0006
709 DELUSION 9 0.0006
710 EJECTION FRACTION DECREASED 9 0.0006
711 PYELONEPHRITIS 5 0.0006
712 UNINTENDED PREGNANCY 6 0.0006
713 LETHARGY 33 0.0006
714 COORDINATION ABNORMAL 8 0.0006
715 CYANOSIS 9 0.0006
716 LYMPHOCYTE COUNT DECREASED 10 0.0006
717 ABSCESS 9 0.0006
718 GYNAECOMASTIA 17 0.0005
719 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 16 0.0005
720 NERVOUS SYSTEM DISORDER 17 0.0005
721 CONVULSION 31 0.0005
722 DIABETIC KETOACIDOSIS 13 0.0005
723 MITRAL VALVE INCOMPETENCE 6 0.0005
724 CIRCULATORY COLLAPSE 9 0.0005
725 DRUG INTOLERANCE 51 0.0005
726 OSTEOPENIA 8 0.0005
727 AORTIC ANEURYSM 4 0.0005
728 RASH 229 0.0005
729 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
730 EYELID OEDEMA 6 0.0005
731 LUNG INFECTION 8 0.0005
732 NAUSEA 407 0.0005
733 APNOEA 4 0.0005
734 VIRAL INFECTION 17 0.0005
735 LUNG DISORDER 25 0.0005
736 AFFECTIVE DISORDER 4 0.0005
737 NEUROLEPTIC MALIGNANT SYNDROME 6 0.0005
738 SALIVARY HYPERSECRETION 5 0.0005
739 RESPIRATORY TRACT INFECTION 13 0.0005
740 OSTEOMYELITIS 9 0.0005
741 CHEST PAIN 91 0.0005
742 MOTOR DYSFUNCTION 5 0.0005
743 RED BLOOD CELL COUNT DECREASED 14 0.0005
744 APATHY 7 0.0005
745 TENDERNESS 5 0.0005
746 GASTROINTESTINAL HAEMORRHAGE 40 0.0005
747 PLATELET COUNT DECREASED 51 0.0005
748 DERMATITIS 10 0.0005
749 PNEUMONIA 154 0.0005
750 CEREBRAL HAEMORRHAGE 17 0.0005
751 IMMUNODEFICIENCY 7 0.0005
752 HYPOPHAGIA 12 0.0005
753 HAEMORRHAGE INTRACRANIAL 7 0.0005
754 BLOOD PRESSURE DECREASED 31 0.0005
755 ARTHRALGIA 193 0.0005
756 DYSURIA 17 0.0005
757 CHILLS 54 0.0005
758 VISUAL IMPAIRMENT 57 0.0005
759 OEDEMA PERIPHERAL 56 0.0005
760 MUCOSAL INFLAMMATION 12 0.0005
761 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
762 CHOLELITHIASIS 15 0.0005
763 WEIGHT DECREASED 127 0.0005
764 ASTHENIA 171 0.0005
765 INTERSTITIAL LUNG DISEASE 22 0.0005
766 MYALGIA 77 0.0005
767 ABDOMINAL DISTENSION 47 0.0004
768 DEHYDRATION 60 0.0004
769 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
770 BODY TEMPERATURE INCREASED 9 0.0004
771 HYPERGLYCAEMIA 16 0.0004
772 URINARY INCONTINENCE 13 0.0004
773 SCAB 5 0.0004
774 CARDIO-RESPIRATORY ARREST 18 0.0004
775 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
776 RASH MACULAR 15 0.0004
777 MOUTH ULCERATION 9 0.0004
778 VENTRICULAR TACHYCARDIA 7 0.0004
779 PHOTOSENSITIVITY REACTION 7 0.0004
780 DIALYSIS 6 0.0004
781 SYSTEMIC LUPUS ERYTHEMATOSUS 15 0.0004
782 MUSCULAR WEAKNESS 48 0.0004
783 PARALYSIS 6 0.0004
784 PRURITUS 160 0.0004
785 AFFECT LABILITY 4 0.0004
786 HEPATITIS C 5 0.0004
787 ERYTHEMA 85 0.0004
788 SCHIZOPHRENIA 5 0.0004
789 CARDIOMEGALY 5 0.0004
790 PHARYNGITIS 5 0.0004
791 COUGH 112 0.0004
792 CYTOKINE RELEASE SYNDROME 8 0.0004
793 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
794 MUSCLE ATROPHY 5 0.0004
795 INCORRECT DRUG ADMINISTRATION DURATION 11 0.0004
796 MUSCULOSKELETAL CHEST PAIN 6 0.0004
797 CARDIAC FAILURE 31 0.0004
798 HALLUCINATION 29 0.0004
799 SOMNOLENCE 77 0.0004
800 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
801 DRUG INEFFECTIVE 502 0.0004
802 DYSPNOEA 215 0.0004
803 LOSS OF CONSCIOUSNESS 48 0.0004
804 PRESYNCOPE 9 0.0004
805 POST PROCEDURAL COMPLICATION 7 0.0004
806 WHITE BLOOD CELL COUNT DECREASED 39 0.0004
807 BLINDNESS UNILATERAL 5 0.0004
808 ABNORMAL BEHAVIOUR 14 0.0004
809 BRONCHOSPASM 5 0.0004
810 PREGNANCY 7 0.0003
811 ABORTION SPONTANEOUS 14 0.0003
812 SKIN DISCOLOURATION 16 0.0003
813 PARANOIA 6 0.0003
814 PULMONARY EMBOLISM 33 0.0003
815 URTICARIA 58 0.0003
816 HYPOKINESIA 5 0.0003
817 SKIN EXFOLIATION 29 0.0003
818 FLUID OVERLOAD 5 0.0003
819 VISION BLURRED 47 0.0003
820 DIARRHOEA 220 0.0003
821 AGGRESSION 17 0.0003
822 OXYGEN SATURATION DECREASED 19 0.0003
823 RENAL INJURY 10 0.0003
824 RESPIRATORY DISORDER 10 0.0003
825 APHASIA 10 0.0003
826 SYNCOPE 33 0.0003
827 RESTLESSNESS 12 0.0003
828 DEVICE RELATED INFECTION 5 0.0003
829 DRUG EXPOSURE DURING PREGNANCY 11 0.0003
830 COGNITIVE DISORDER 15 0.0003
831 ABDOMINAL PAIN UPPER 66 0.0003
832 MELAENA 7 0.0003
833 ARTHRITIS 25 0.0003
834 SENSORY DISTURBANCE 5 0.0003
835 MOVEMENT DISORDER 10 0.0003
836 UNRESPONSIVE TO STIMULI 8 0.0003
837 PALPITATIONS 36 0.0003
838 ORAL HERPES 6 0.0003
839 ACUTE MYOCARDIAL INFARCTION 9 0.0003
840 EYE DISORDER 10 0.0003
841 BRADYCARDIA 16 0.0003
842 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
843 IRRITABILITY 18 0.0003
844 MENSTRUATION IRREGULAR 8 0.0003
845 FEAR 8 0.0003
846 HYPERSENSITIVITY 55 0.0003
847 TREMOR 49 0.0003
848 COLITIS 11 0.0003
849 BLISTER 16 0.0003
850 DISTURBANCE IN ATTENTION 15 0.0003
851 DYSSTASIA 8 0.0003
852 HYPOAESTHESIA 41 0.0003
853 DIZZINESS 136 0.0003
854 SLEEP DISORDER 19 0.0003
855 EYE PAIN 15 0.0003
856 PHOTOPHOBIA 5 0.0003
857 CARDIAC FAILURE CONGESTIVE 21 0.0003
858 NIGHTMARE 9 0.0003
859 HYPERTENSION 55 0.0003
860 AGITATION 19 0.0003
861 HEART RATE DECREASED 9 0.0003
862 HYPERHIDROSIS 33 0.0003
863 GAIT DISTURBANCE 48 0.0003
864 SPINAL FRACTURE 5 0.0002
865 THERAPEUTIC RESPONSE DECREASED 15 0.0002
866 THERAPEUTIC PRODUCT EFFECT DECREASED 11 0.0002
867 ANGINA PECTORIS 7 0.0002
868 HEADACHE 153 0.0002
869 DYSPEPSIA 24 0.0002
870 BURNING SENSATION 17 0.0002
871 INFECTION 35 0.0002
872 MALAISE 106 0.0002
873 PARAESTHESIA 38 0.0002
874 PULMONARY HYPERTENSION 5 0.0002
875 URINARY RETENTION 8 0.0002
876 ADVERSE EVENT 22 0.0002
877 FLUSHING 24 0.0002
878 EATING DISORDER 5 0.0002
879 SKIN ULCER 6 0.0002
880 FAECES DISCOLOURED 5 0.0002
881 HAEMORRHAGE 24 0.0002
882 DEPRESSED MOOD 12 0.0002
883 LIMB DISCOMFORT 7 0.0002
884 FEBRILE NEUTROPENIA 15 0.0002
885 DYSPHAGIA 21 0.0002
886 NEUTROPHIL COUNT DECREASED 9 0.0002
887 CATARACT 13 0.0002
888 POLLAKIURIA 9 0.0002
889 DEMENTIA 6 0.0002
890 SWELLING 20 0.0002
891 HEART RATE INCREASED 21 0.0002
892 FUNGAL INFECTION 7 0.0002
893 SPEECH DISORDER 11 0.0002
894 PRODUCT USE ISSUE 39 0.0002
895 DEPRESSION 47 0.0002
896 NEURALGIA 5 0.0002
897 ABASIA 5 0.0002
898 ABDOMINAL PAIN LOWER 5 0.0002
899 VERTIGO 12 0.0002
900 SUICIDAL IDEATION 18 0.0002
901 URINARY TRACT INFECTION 33 0.0002
902 HAEMATOMA 5 0.0002
903 DEATH 164 0.0002
904 ANHEDONIA 5 0.0002
905 DYSPNOEA EXERTIONAL 7 0.0002
906 ACNE 14 0.0002
907 SWELLING FACE 12 0.0002
908 LIP SWELLING 6 0.0002
909 NECK PAIN 10 0.0002
910 CELLULITIS 9 0.0002
911 TYPE 2 DIABETES MELLITUS 6 0.0002
912 ATRIAL FIBRILLATION 17 0.0002
913 HERPES ZOSTER 10 0.0002
914 INSOMNIA 46 0.0002
915 BLOOD CHOLESTEROL INCREASED 8 0.0002
916 DIABETES MELLITUS 13 0.0002
917 INFLUENZA LIKE ILLNESS 14 0.0002
918 FATIGUE 131 0.0002
919 WITHDRAWAL SYNDROME 7 0.0002
920 LACRIMATION INCREASED 5 0.0002
921 SUICIDE ATTEMPT 10 0.0002
922 STOMATITIS 10 0.0002
923 RECTAL HAEMORRHAGE 7 0.0002
924 VAGINAL HAEMORRHAGE 7 0.0002
925 ABDOMINAL DISCOMFORT 27 0.0002
926 WEIGHT INCREASED 36 0.0002
927 INTENTIONAL PRODUCT MISUSE 14 0.0002
928 CHRONIC KIDNEY DISEASE 12 0.0002
929 JOINT SWELLING 19 0.0002
930 CHEST DISCOMFORT 16 0.0002
931 COMPLETED SUICIDE 13 0.0002
932 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 8 0.0002
933 GAIT INABILITY 5 0.0001
934 ILL-DEFINED DISORDER 9 0.0001
935 EPISTAXIS 11 0.0001
936 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 10 0.0001
937 MYOCARDIAL INFARCTION 24 0.0001
938 BACK PAIN 31 0.0001
939 PAIN IN EXTREMITY 39 0.0001
940 RENAL DISORDER 6 0.0001
941 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
942 MEDICATION ERROR 7 0.0001
943 MUSCULOSKELETAL STIFFNESS 11 0.0001
944 MOBILITY DECREASED 9 0.0001
945 BLOOD GLUCOSE DECREASED 6 0.0001
946 CEREBROVASCULAR ACCIDENT 21 0.0001
947 RHINORRHOEA 8 0.0001
948 DYSKINESIA 5 0.0001
949 ALOPECIA 23 0.0001
950 ANXIETY 33 0.0001
951 BALANCE DISORDER 10 0.0001
952 MEMORY IMPAIRMENT 15 0.0001
953 HAEMATOCHEZIA 6 0.0001
954 ARTHROPATHY 6 0.0001
955 CONSTIPATION 23 0.0001
956 OCULAR HYPERAEMIA 5 0.0001
957 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
958 PERIPHERAL SWELLING 16 0.0001
959 MUSCLE SPASMS 19 0.0001
960 DISCOMFORT 6 0.0001
961 DRY SKIN 13 0.0001
962 PAIN 59 0.0001
963 ECZEMA 5 0.0001
964 INTENTIONAL OVERDOSE 6 0.0001
965 AMNESIA 6 0.0001
966 ADVERSE DRUG REACTION 8 0.0001
967 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
968 THROMBOSIS 7 0.0001
969 WHEEZING 5 0.0001
970 COVID-19 14 0.0001
971 SINUSITIS 8 0.0001
972 CARDIAC DISORDER 7 0.0001
973 RHEUMATOID ARTHRITIS 8 0.0001
974 SKIN BURNING SENSATION 5 0.0001
975 FALL 23 0.0001
976 UNEVALUABLE EVENT 5 0.0001
977 OVERDOSE 14 0.0001
978 OROPHARYNGEAL PAIN 6 0.0001
979 BLOOD GLUCOSE INCREASED 12 0.0001
980 ASTHMA 7 0.0001
981 HOSPITALISATION 9 0.0001
982 ILLNESS 6 0.0001
983 INFLUENZA 6 0.0001
984 CONTUSION 5 0.0001
985 INCORRECT DOSE ADMINISTERED 10 0.0000
986 EMOTIONAL DISTRESS 5 0.0000
987 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
988 PSORIASIS 5 0.0000
989 DRUG DOSE OMISSION 6 0.0000
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
991 PRODUCT DOSE OMISSION ISSUE 8 0.0000
992 FEELING ABNORMAL 6 0.0000